Paulson & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Paulson & Co’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,103,046	Closed	-$243M	–	18
2023 Q3	$243M	Buy	2,103,046 +1,603,046	+321%	+$172M	21.77%	1
2023 Q2	$51.4M	Sell	500,000 -500,000	-50%	-$52.8M	5.02%	7
2023 Q1	$109M	Sell	1,000,000 -500,000	-33%	-$55.3M	9.07%	5
2022 Q4	$171M	Sell	1,500,000 -4,600,000	-75%	-$382M	15.37%	2
2022 Q3	$378M	Sell	6,100,000 -99,000	-2%	-$6.92M	27.63%	1
2022 Q2	$494M	Buy	6,199,000 +585,000	+10%	+$55.4M	24.38%	1
2022 Q1	$591M	Sell	5,614,000 -386,000	-6%	-$37.6M	18.18%	1
2021 Q4	$647M	Sell	6,000,000 -169,296	-3%	-$18.5M	19.94%	2
2021 Q3	$676M	Sell	6,169,296 -1,822,144	-23%	-$189M	19.25%	2
2021 Q2	$748M	Hold	7,991,440	–	–	17.88%	2
2021 Q1	$736M	Hold	7,991,440	–	–	16.89%	2
2020 Q4	$585M	Buy	7,991,440 +1,300,001	+19%	+$96.6M	15.17%	1
2020 Q3	$520M	Sell	6,691,439 -200,000	-3%	-$13.8M	16.2%	1
2020 Q2	$383M	Sell	6,891,439 -1,279,261	-16%	-$54.7M	12.24%	2
2020 Q1	$242M	Hold	8,170,700	–	–	9.23%	3
2019 Q4	$296M	Hold	8,170,700	–	–	6.38%	5
2019 Q3	$222M	Buy	8,170,700 +1,500,000	+22%	+$38.8M	4.46%	9
2019 Q2	$160M	Hold	6,670,700	–	–	2.73%	16
2019 Q1	$176M	Sell	6,670,700 -500,000	-7%	-$11.8M	3.7%	10
2018 Q4	$140M	Hold	7,170,700	–	–	3.36%	9
2018 Q3	$140M	Sell	7,170,700 -500,000	-7%	-$9.51M	2.63%	13
2018 Q2	$127M	Hold	7,670,700	–	–	2.59%	11
2018 Q1	$109M	Sell	7,670,700 -200,000	-3%	-$2.95M	2.38%	12
2017 Q4	$115M	Buy	7,870,700 +2,291,850	+41%	+$32.2M	2.24%	14
2017 Q3	$70.7M	Buy	5,578,850 +643,350	+13%	+$8.18M	1.27%	18
2017 Q2	$58.6M	Buy	+4,935,500	New	+$61.4M	0.79%	29

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Paulson & Co's HZNP Position: Q4 2023 in Review

Paulson & Co sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,103,046 shares — an estimated $243M sold.

Paulson & Co first reported a position in HZNP in Q2 2017 and held it in 26 quarters. The position peaked at $748M in Q2 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Paulson & Co reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Paulson & Co sold 2,103,046 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $243M.
Paulson & Co first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 26 quarters.
Paulson & Co's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $748M in Q2 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Paulson & Co's 13F filing for Q4 2023, filed 14 Feb 2024.